News
Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...
How can early decisions in cell and gene therapy clinical development impact downstream progress toward commercialization and ...
How specialized expertise, advanced infrastructure, and strategic partnerships are enabling the next generation of cell-based ...
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing ...
The body changes capecitabine into a common chemotherapy drug called fluorouracil. It stops cells from making and repairing DNA ... You should contact your advice line urgently if you think you have ...
You take capecitabine as a tablet ... You should contact your advice line urgently if you think you have an infection. You might be breathless and look pale due to a drop in red blood cells. This is ...
To address this, researchers developed a "cell line atlas," which is a collection of cancer cell lines—each derived from an individual patient's tumor and adapted to grow in the lab—with ...
But many envision a future where producer cell lines will take over for large-scale production. Here’s what to know about AAV producer cell lines for gene therapies. Producer cell lines are ...
2,3 In patients with PD-L1 CPS <1 recommended first-line treatment is trastuzumab plus platinum-based chemotherapy (cisplatin plus 5-FU or oxaliplatin plus capecitabine ... Unresectable or metastatic ...
“So many people don’t realize how important fetal cell lines are to develop life-saving medicines and vaccines that they rely on every day,” says Amesh Adalja, an infectious disease expert ...
9 15 19 These findings suggest that the combination of programmed cell death protein 1 inhibitors ... from the nab-TPC regimen as a first line treatment. This study compared nab-paclitaxel, cisplatin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results